Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Fistula × pasireotide × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 4 Pituitary Neoplasms 4 Pancreatic Neoplasms 4 Neuroendocrine Tumors 4 Gastro-enteropancreatic neuroendocrine tumor 3 Carcinoid Tumor 3 Pituitary ACTH Hypersecretion 2 Neoplasms 2 Neoplasm Metastasis 2 Nelson Syndrome 2 Acromegaly 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Serotonin Syndrome 1 Sarcoma, Synovial 1 Prolactinoma 1 Prolactin-Producing Pituitary Tumor 1 Primary Inoperable Thymoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1 Pancreatic Fistula 1 Neuroectodermal Tumors, Primitive 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Meningioma 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1

Interventions

Pancreaticoduodenectomy 4 pasireotide 1 glubran 2 1 Radiosurgery 1 Polygeline 1 Pancreaticojejunostomy 1 Neoprene 1 Laparotomy 1 Hydrocortisone 1 Anti-Bacterial Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02775227 2020-08-24

HYPAR

Helsinki University Central Hospital

Phase 4 Active not recruiting

Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡